Inventor · disambiguated record
Longchuan Bai
Also filed as: BAI LONGCHUAN
12 granted patents·12 pending applications·119 citations·filing 2009–2023
90Inventor score
Files withUNIV MICHIGAN REGENTS12UNIV MICHIGAN7WANG SHAOMENG3JIANGSU ASCENTAGE BIOMED DEV INC1REGENTS OF THE UNIV OF MICHICAN1
Top patents by PatentIndex Score
24 records- 0194US10253044B29H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 9, 2019·11 cites·14 claims
- 0294US8691184B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameWANG SHAOMENG·Filed 2012·Granted Apr 8, 2014·42 cites·15 claims
- 0392US9403856B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2015·Granted Aug 2, 2016·15 cites·2 claims
- 0490US9580430B29H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2015·Granted Feb 28, 2017·7 cites·18 claims
- 0589US9675697B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jun 13, 2017·16 cites·21 claims
- 0689US9096625B2BCL-2/BCL-XL inhibitors and therapeutic methods using the sameUNIV MICHIGAN·Filed 2014·Granted Aug 4, 2015·18 cites·18 claims
- 0785US10391175B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2017·Granted Aug 27, 2019·6 cites·18 claims
- 0879US10759808B2Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2017·Granted Sep 1, 2020·2 cites·20 claims
- 0968US9783539B2Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitorsJIANGSU ASCENTAGE BIOMED DEV INC·Filed 2014·Granted Oct 10, 2017·2 cites·20 claims
- 1062US2024059704A1Cereblon Ligands and Uses ThereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 1161US2023295200A1STAT5 and STAT6 Inhibitors and Uses ThereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 1261US2024059711A1Cereblon Ligands and Uses ThereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 1360US2025195484A1Cereblon ligands and uses thereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 1460US2023295197A1STAT5 and STAT6 Degraders and Uses ThereofREGENTS OF THE UNIV OF MICHICAN·Filed 2023·Application pending·0 cites
- 1559US2025215012A1Ikzf2 degraders and uses thereofUNIV MICHIGAN·Filed 2023·Application pending·0 cites
- 1657US2021002289A1Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1756US2023133504A1Method of treating graft-versus-host diseaseUNIV MICHIGAN·Filed 2022·Application pending·0 cites
- 1854US2024166647A1Cereblon LigandsUNIV MICHIGAN REGENTS·Filed 2022·Application pending·0 cites
- 1952US2011319362A1Stat3 ligands and therapeutic uses thereofWANG SHAOMENG·Filed 2009·Application pending·0 cites
- 2047US2023083015A1Small molecule degraders of stat3UNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 2141US11267822B2BET bromodomain protein degraders with cleavable linkersUNIV MICHIGAN REGENTS·Filed 2018·Granted Mar 8, 2022·0 cites·19 claims
- 2239US11466028B2Fused 1,4-oxazepines as BET protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Oct 11, 2022·0 cites·19 claims
- 2338US10633386B2BET protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 28, 2020·0 cites·19 claims
- 2436US2012302629A1Biomarkers for gossypol chemotherapy and methods of treating diseaseWANG SHAOMENG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Longchuan Bai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →